Follow the Marksans Pharma Limited share price and the full insider trade history of the company, a listed equity based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Marksans Pharma Limited has recorded 13 insider filings. Market capitalisation: €117.1bn. The latest transaction was reported on 6 June 2024 (Purchase). Among the most active insiders: Arvind Singh. Every trade is free.
13
Insider Decl.
n/a
Thresholds
€1m
7 ops.
Buy Volume
€31,575
6 ops.
Sell Volume
10Σ signal
Buys €1m€31,575 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,523 of 29,062 companies
61.8
score / 100
Value
46
Quality
77
FCF yld2.8%
Earn yld3.6%
EV/EBITDA17.6x
ROE15%
Gross mgn57%
Net mgn14%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,000,000 shares@ ₹74.00100.0% of flowEquity SharesSEBI:cca991f42231edd239ddfebdb5677a9dbbdc2720
13 of 13 declarations
About Marksans Pharma Limited
Marksans Pharma Limited is a pharmaceutical company that specializes in the manufacturing of generic drugs and health products. It is listed on the XBOM market.